Drug
Ab680
Ab680: highest development phase Phase 1/2, developed by Arcus Biosciences. 4 trial records tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Arcus Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| AB680 NCT04660812 | Phase 1/2 | Metastatic Colorectal Cancer |
| AB680 NCT03677973 | Phase 1 | Healthy Volunteers |
| AB680 NCT04104672 | Phase 1 | Advanced Pancreatic Cancer |
| AB680 NCT04575311 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Ab680 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.